Ready To Welcome To...
Health Care: Health Services
BG Medicine Inc. (BGMD: NASDAQ)
$1.72 -0.07 | -3.91%
05/24/13 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with BGMD
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorUnder-$10 Setting Up To Tra...
- Contributor8 Health Care Stocks With R...
Latest BGMD Headlines from TheStreet
- BG Medicine Welcomes CE Mark For Galectin-3 Test 04.10.13 | 08:04 am
- BG Medicine Reports Fourth Quarter And Full Year 2012 Financial Results And Provides 2013 Outlook 03.13.13 | 07:03 am
- BG Medicine To Announce Fourth Quarter And Year-End 2012 Financial Results And Host Conference Call On Wednesday, March 13, 2013 03.06.13 | 08:03 am
- BG Medicine Highlights Role Of Galectin-3 Testing In Combating Hospital Readmissions At The American College Of Cardiology's (ACC) 62nd Annual Scientific Session & Expo 03.06.13 | 08:03 am
- BG Medicine, Inc. To Present At Cowen And Company 33rd Annual Health Care Conference 02.27.13 | 08:02 am
- BG Medicine, Inc. Announces Publication Of Two Studies Supporting Repeat Galectin-3 Testing In Heart Failure Patients 02.27.13 | 08:02 am
- 5 Stocks With Big Insider Buying 02.06.13 | 12:02 pm
- BG Medicine, Inc. Announces Closing Of Public Offering And Exercise Of Over-Allotment Option 01.30.13 | 04:01 pm
- BG Medicine, Inc. Prices $12.0 Million Public Offering Of Common Stock 01.25.13 | 09:01 am
- BG Medicine, Inc. Enters Into $12 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC 01.24.13 | 04:01 pm
Press Releases for BGMD
- Abbott's Galectin-3 Test Provides Doctors In Europe With New Tool For Assessing The Prognosis Of Chronic Heart Failure Patients - PR Newswire 04.10.13 | 08:04 am
- Health Diagnostic Laboratory, Inc. (HDL, Inc.) Announces Availability Of Galectin-3 Testing Service In Partnership With BG Medicine - PR Newswire 03.24.11 | 08:03 am
- BG Medicine Announces Exercise Of Underwriters’ Over-Allotment Option And Closing Of Initial Public Offering - Business Wire 02.09.11 | 04:02 pm
- BG Medicine Announces Pricing Of Initial Public Offering - Business Wire 02.04.11 | 08:02 am
Partner Headlines for BGMD
- Pre-Market Most Active for Dec 12, 2012 : TLAB, QQQ, NRF, STM, BAC, NOK, LLY, AIG, SIRI, BGMD, FB, AAPL - NASDAQ 12.12.12 | 01:12 pm
- 4 Undervalued And Technically Oversold Healthcare Penny Stocks Poised To Bounce - Seeking Alpha 11.20.12 | 09:11 am
- UPDATE: Ladenburg Thalmann Raises PT to $16.50 on BG Medicine - Benzinga 02.14.12 | 01:02 pm
- Market Update - Benzinga 01.09.12 | 09:01 am
